这篇文章不错，转发给_老虎社区_美港股上老虎 - 老虎社区

点赞
评论
收藏

百惠778899
2022-04-06

这篇文章不错，转发给大家看

腾盛博药宣布4月将出席多个投资者会议

@腾盛博药2137HK：

关于$腾盛博药-B(02137)$ 腾盛博药生物科技有限公司（“腾盛博药”；股份代号：2137.HK）是一家位于中国及美国的生物技术公司，致力于针对中国及全球重大感染性疾病（如乙型肝炎、COVID-19、人类免疫缺陷病毒 (HIV) 感染、多重耐药 (MDR) 或广泛耐药性 (XDR) 革兰氏阴性菌感染）及其它具有重大公共卫生负担的疾病（如中枢神经系统 (CNS) 疾病）开发创新疗法。欲了解更多信息

腾盛博药宣布4月将出席多个投资者会议

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

点赞

举报

评论

推荐
最新

empty

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

老虎社区侵权投诉指引

中国互联网举报中心·北京互联网举报中心

网络谣言曝光台·扫黄打非举报中心

网络110报警服务

© 2018-2024 老虎社区版权所有

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

qrcode

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":619854287,"tweetId":"619854287","gmtCreate":1649211358778,"gmtModify":1649211358778,"author":{"id":3585548756248504,"idStr":"3585548756248504","authorId":3585548756248504,"authorIdStr":"3585548756248504","name":"百惠778899","avatar":"https://static.tigerbbs.com/2e6a5f6bb5a1e844bff5ad96d4e2f085","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":2,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body>\n这篇文章不错，转发给大家看</body></html>","htmlText":"<html><head></head><body>\n这篇文章不错，转发给大家看</body></html>","text":"这篇文章不错，转发给大家看","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/619854287","repostId":610793178,"repostType":1,"repost":{"magic":2,"id":610793178,"tweetId":"610793178","gmtCreate":1648772444620,"gmtModify":1648778011493,"author":{"id":4088222930030430,"idStr":"4088222930030430","authorId":4088222930030430,"authorIdStr":"4088222930030430","name":"腾盛博药2137HK","avatar":"https://static.tigerbbs.com/7225daebeee9c083bcbed970259d2446","vip":5,"userType":5,"introduction":"致力于服务患者需求,提升中国公共医疗保健水平","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":4663,"starInvestorFlag":false},"themes":[],"images":[{"img":"https://static.tigerbbs.com/59ecc27029033a513922dc6f493cb311","width":"-1","height":"-1"},{"img":"https://static.tigerbbs.com/4dcef7789f99efdc42888e00882a3acf","width":"632","height":"1506"},{"img":"https://static.tigerbbs.com/6a8c975470c42b4d4fc1dad32b14abb1","width":"632","height":"590"}],"coverImages":[{"img":"https://static.tigerbbs.com/59ecc27029033a513922dc6f493cb311","width":"-1","height":"-1"},{"img":"https://static.tigerbbs.com/4dcef7789f99efdc42888e00882a3acf","width":"632","height":"1506"},{"img":"https://static.tigerbbs.com/6a8c975470c42b4d4fc1dad32b14abb1","width":"632","height":"590"}],"title":"腾盛博药宣布4月将出席多个投资者会议","extraTitle":"","html":"<html><head></head><body><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/59ecc27029033a513922dc6f493cb311\" tg-width=\"-1\" tg-height=\"-1\"></p> <p class=\"t-img-caption\"><img referrerpolicy=\"no-referrer\" src=\"https://static.tigerbbs.com/6a8c975470c42b4d4fc1dad32b14abb1\" tg-width=\"632\" tg-height=\"590\"></p> <p class=\"t-img-caption\"><img referrerpolicy=\"no-referrer\" src=\"https://static.tigerbbs.com/4dcef7789f99efdc42888e00882a3acf\" tg-width=\"632\" tg-height=\"1506\"></p> <p><b>关于</b><a target=\"_blank\" href=\"https://laohu8.com/S/02137\">$腾盛博药-B(02137)$</a>&nbsp;&nbsp;</p> <p>腾盛博药生物科技有限公司（“腾盛博药”；股份代号：2137.HK）是一家位于中国及美国的生物技术公司，致力于针对中国及全球重大感染性疾病（如乙型肝炎、COVID-19、人类免疫缺陷病毒 (HIV) 感染、多重耐药 (MDR) 或广泛耐药性 (XDR) 革兰氏阴性菌感染）及其它具有重大公共卫生负担的疾病（如中枢神经系统 (CNS) 疾病）开发创新疗法。欲了解更多信息</p></body></html>","htmlText":"<html><head></head><body><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/59ecc27029033a513922dc6f493cb311\" tg-width=\"-1\" tg-height=\"-1\"></p> <p class=\"t-img-caption\"><img referrerpolicy=\"no-referrer\" src=\"https://static.tigerbbs.com/6a8c975470c42b4d4fc1dad32b14abb1\" tg-width=\"632\" tg-height=\"590\"></p> <p class=\"t-img-caption\"><img referrerpolicy=\"no-referrer\" src=\"https://static.tigerbbs.com/4dcef7789f99efdc42888e00882a3acf\" tg-width=\"632\" tg-height=\"1506\"></p> <p><b>关于</b><a target=\"_blank\" href=\"https://laohu8.com/S/02137\">$腾盛博药-B(02137)$</a>&nbsp;&nbsp;</p> <p>腾盛博药生物科技有限公司（“腾盛博药”；股份代号：2137.HK）是一家位于中国及美国的生物技术公司，致力于针对中国及全球重大感染性疾病（如乙型肝炎、COVID-19、人类免疫缺陷病毒 (HIV) 感染、多重耐药 (MDR) 或广泛耐药性 (XDR) 革兰氏阴性菌感染）及其它具有重大公共卫生负担的疾病（如中枢神经系统 (CNS) 疾病）开发创新疗法。欲了解更多信息</p></body></html>","text":"关于$腾盛博药-B(02137)$ 腾盛博药生物科技有限公司（“腾盛博药”；股份代号：2137.HK）是一家位于中国及美国的生物技术公司，致力于针对中国及全球重大感染性疾病（如乙型肝炎、COVID-19、人类免疫缺陷病毒 (HIV) 感染、多重耐药 (MDR) 或广泛耐药性 (XDR) 革兰氏阴性菌感染）及其它具有重大公共卫生负担的疾病（如中枢神经系统 (CNS) 疾病）开发创新疗法。欲了解更多信息","highlighted":1,"essential":1,"paper":2,"link":"https://laohu8.com/post/610793178","repostId":0,"isVote":1,"tweetType":1,"commentLimit":10,"symbols":["02137"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":323,"xxTargetLangEnum":"ZH_CN"},"isVote":1,"tweetType":1,"viewCount":1163,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":25,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}